ADITEC’s research partners are mainly based in Europe, but also excellent groups from the US join the project. Scientists from 13 countries and 42 research partners collaborate in the ADITEC project:
Austria
- Valneva Austria GmbH (formerly Intercell)
- Institute for Biomedical Aging Research / University of Innsbruck
- Hookipa Biotech GmbH
Belgium
Denmark
France
- Institut Pasteur
- French Atomic Energy
- Institut de Biologie et Chimie des Protéines (CNRS)
- Medicine in need
Germany
Iceland
Ireland
Italy
- Sclavo Vaccines Association
- GlaxoSmithKline Vaccine
- University of Siena
- Fondazione Humanitas per la Ricerca
- Istituto Superiore di Sanità
- ALTA s.r.l.u.
- REITHERA srl
- Microbiotec s.r.l.
- GSK VACCINES INSTITUTE FOR GLOBAL HEALTH SRL
- VisMederi s.r.l.
Norway
Sweden
- University of Gothemburg
- Duotol AB
- Abera Bioscience AB
Switzerland
The Netherlands
- Leiden University Medical Center
- Tuberculosis Vaccine Initiative
- Utrecht University
- Erasmus Medical Center
- Crossbeta Biosciences
- Bioneedle Group
United Kingdom
- University of Surrey
- University of Oxford
- Kings College London
- National Institute for Biological Standards and Control / Medicines and Healthcare Products Regulatory Agency (MHRA/NIBSC)
- Imperial College London
United States of America
You must be logged in to post a comment.